Home › Trial NCT01100242
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
- Trial IDNCT01100242
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorNew Mexico Cancer Research Alliance
- Enrollment17
- Start date2010-04
- ConditionsMetastatic Renal Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.